Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
5 min read
Sam North
Medical cannabis has been a legal treatment option in the UK since November 1, 2018, but it has only become more 'popular' in the past year or so. Patient numbers are now skyrocketing, and thanks to Releaf partnering with Glass Pharms® and SOMAI Pharmaceuticals®, the supply chain is rapidly improving, with a range of new products being made available to patients.
But one question that almost always comes up when discussing medical cannabis in the UK is...
No, and there are a few reasons for this.
The law is extremely clear.
No matter if you are prescribed medical cannabis patient or not, growing cannabis at home is illegal. There are zero concessions made for medical cannabis patients, and if you are caught growing even one plant, you could face heavy penalties - both fines and jail time.
There are three main reasons the government gives as to why home cultivation is prohibited in the UK, even for medical cannabis patients.
In the UK, all medical cannabis products must be prescribed by a specialist doctor and dispensed through a registered pharmacy. This strict regulation ensures that patients are receiving safe, tested, and standardised products.
The level of regulatory oversight that all medical cannabis grown in the UK must go through is simply not possible for home cultivation. As a result, the government has chosen to prohibit it entirely to maintain quality control, safety, and accountability.
All cannabis grown for medical purposes in the UK (or imported) is subject to strict testing and quality control measures set by the Medicines and Healthcare products Regulatory Agency (MHRA).
This helps ensure that all patients receive safe and effective medications with consistent levels of cannabinoids and terpenes, the two main groups of therapeutically active compounds.
Keep in mind that cannabis, like any plant, can have genetic variations and inconsistent potency, especially when grown in unregulated environments. It’s also vulnerable to pests and mould, which is why all UK medical cannabis undergoes strict testing to ensure it meets the highest safety and quality standards.
One of the issues with allowing home weed cultivation is the potential for misuse. Without proper oversight and regulation, there is a risk that cannabis grown for personal medical use could end up on the black market.
There are two routes for UK patients to access medical cannabis legally.
The first is through the NHS, but there is one glaring caveat - the NHS will only prescribe medical cannabis products for patients with rare and severe forms of epilepsy, muscle spasticity caused by multiple sclerosis, or for patients undergoing chemotherapy who are struggling with heavy nausea or vomiting.
That is why the overwhelming (over 99%) majority of UK medical cannabis patients access their medication through private clinics like Releaf.
Specialist doctors working with private clinics like Releaf have more flexibility in prescribing medical cannabis treatments. This means that patients with a much wider range of health matters, including (but not limited to):
Before Releaf entered the market in 2024, the issues surrounding medical cannabis access in the UK were at an all-time high. Patients were struggling to find reliable and affordable sources of medication, with the whole market relying on expensive imports and limited choices.
In June 2024, we partnered with Glass Pharms® with a clear vision to improve the medical cannabis supply chain. Thanks to this partnership, Releaf patients were the first in the UK to be prescribed domestically grown medical cannabis, providing safe, consistent, and affordable options for those in need.
To strengthen the supply chain and give patients more options, Releaf has also teamed up with SOMAÍ Pharmaceuticals. This collaboration gives Releaf patients exclusive access to SOMAÍ's Indica Essentials product line, featuring a variety of THC/CBD ratios and terpene profiles designed to support a wide range of medical conditions.
So, to answer the question,
"Can UK medical cannabis patients legally grow their own plants?"
No. Home growing isn't allowed, even for medical patients, because of strict rules to keep medical cannabis safe, consistent, and properly regulated.
Thanks to the partnerships between Releaf, Glass Pharms, and SOMAÍ, patients now have access to an unparalleled selection of high-quality, highly regulated medical cannabis products. The past year has seen exponential improvements in the medical cannabis supply chain, and there’s no sign of this progress slowing anytime soon.
To learn more, check out the rest of our New Patient blog series, or head to our medical cannabis eligibility checker. It takes less than 30 seconds to find out if you potentially qualify for a private medical cannabis prescription with Releaf.
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Sam North, a seasoned writer with over five years' experience and expertise in medicinal cannabis, brings clarity to complex concepts, focusing on education and informed use.
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
World AIDS Day takes place every year on the 1st of December, and has done since 1988. We’d like to honour this year's campaign by raising the awareness of one treatment option many affected by HIV aren’t even aware is available to them: medical cannabis.
Lucy MacKinnon
Last year, our representative research found 68% of UK adults would consider medical cannabis treatment if their doctor recommended it, but around 1 in 4 said they would be apprehensive about, and perhaps discouraged by, the costs involved.
Lucy MacKinnon
Last week, it was Road Safety Awareness Week, an important annual event that aims to raise awareness around road safety and improve funding and care for victims of road traffic accidents.
Emily Ledger
